Clinical Trials on Mild til moderat onykomykose på grunn av dermatofytt in Luxembourg
Totalt 0 resultater
Ingenting funnet
Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.
Sponsorer og samarbeidspartnere
- Medical School University of Zagreb
- Uzès hospital
- First Hospital Affiliated to Baotou Medical College, Baotou, China
- Pyrotech Therapeutics, Inc.
- Etablissement Publique de Santé Mentale de la Réunion
- Marta Camats Terre
- Medtronic Poland Spółka z ograniczoną odpowiedzialnością
- Diabetech
- Ministry of Tourism, Sport and the Arts, British Columbia
- Incept BioSystems, Inc.
- St. Louis Children's Hospital
- ViiV Healthcare Australia Pty. Ltd
- Jadran Galenski laboratorij d.d.Rijeka
- Tianjin Medical University
- CK-CARE (Christine Kühne - Center for Allergy Research and Education)
- MRC/UVRI & LSHTM Uganda Research Unit
- Institutos Nacionales de Salud, USA Instituto Alemán del Cáncer
- Centre de Pharmacologie Clinique, INSERM CIC 501
- Vaxxinity, Inc.
- PharmTest s.r.o.
- Vis full liste
Medisinsk tilstand
- Oralt allergisk syndrom
- Human Papilloma Virus Infeksjon
- Kaste opp
- Native og ventil i aortaklaffsvikt
- Non-sedentary
- Repository Corticotropin Injection
- Post-Cerebrovaskulær Accident (CVA) Hemiparese
- Hepatitt C, behandlingsnaive, genotype 1-pasienter
- Neoplasmer, avansert solid
- Tilbakefallende ondartet solid svulst
- Kritisk sykdom Sepsis, alvorlig
- Fenofibrat
- Familiefunksjon
- Ikke-nartritisk hoftesykdom
- Godt trente idrettsutøvere
- Pulpotomi av unge permanente molarer
- Behandling av brystkreft
- Vasomotoriske symptomer assosiert med overgangsalder
- Central Centrifugal Cicatricial Alopecia (CCCA)
- Beinsykdom med høy turnover
- Vis full liste
Legemiddelintervensjoner
- Oksaliplatin
- 40 consecutive doses of SUF NT 15 mcg taken every 20 minutes
- Svake steroider (Flurolon, Allergan)
- Prazosin
- Fenelzinsulfat
- Keytruda
- ASP2151
- Eksperimentell DW224aa
- Tamsulosin
- Famciclovir
- SHR-1210
- Durvalumab
- 0,45 % saltvann i 5 % dekstrose (intravenøst)
- Sulfasalazine
- SPLA2 Inhibitor
- Karboplatin
- Olorofim
- Ropivakain 0,2 %
- RoActemra sc
- Lidokain
- Vis full liste
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Burundi
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Greece
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Ireland
- Contract Research Organizations in Italy
- Contract Research Organizations in Jordan
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Oman
- Contract Research Organizations in Portugal
- Contract Research Organizations in Singapore
- Contract Research Organizations in Trinidad & Tobago
- CRO list by country